Morning Overview on MSN
Single intramuscular shot shows promise for faster heart attack recovery
A single intramuscular injection of a self-amplifying RNA therapy produced weeks of heart-protective protein in rat models of myocardial infarction, according to a study published in Science on March ...
Morning Overview on MSN
MIT unveils injectable ‘satellite livers’ that self-assemble inside the body
Researchers at MIT have developed injectable tissue grafts, dubbed “satellite livers,” that self-assemble inside the body ...
Researchers developed an RNA-based injection that prompts muscle cells to produce a natural heart-protective hormone for weeks. The sustained signal may reduce cardiac scarring, preserve healthy ...
One experimental injection helped mice and pigs heal after heart attack by boosting a protective heart hormone. (CREDIT: ...
Cabotegravir and rilpivirine (cabenuva), the only complete HIV treatment regimen delivered by injection, could be given by intramuscular injection to the thigh rather than the gluteal muscles, ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...
Please provide your email address to receive an email when new articles are posted on . The approval applies to certain patients with myasthenia gravis or chronic inflammatory demyelinating ...
On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, ...
VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...
WEDNESDAY, April 16, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved a self-injection version of Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for the ...
Key market opportunities in the Prefilled Syringes Market include rapid growth driven by GLP-1 obesity therapeutics and rising self-injection demand, preference for COP over glass to mitigate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results